EventsThe 5th International Online Conference on Nanomaterials
Published
This submission belongs to the session S1. Nanomedicine and Bionanotechnology of the event The 5th International Online Conference on Nanomaterials
Published date
19 Sep, 2025
Academic Editor
author-avatarWan-liang Lu
Citation
Cristina Parisi, Francesca Laneri, Giuseppe Longobardi, Aurore Fraix, Claudia Conte, Arianna Pastore, Mariano Stornaiuolo, Adriana C.E. Graziano, Mimimorena Seggio, Ovidio Catanzano, Fabiana Quaglia, Salvatore Sortino, A Novel Supramolecular Approach for Red-Light-Photosensitized Nitric Oxide Release, in Proceedings of The 5th International Online Conference on Nanomaterials, 22 September–24 September 2025, MDPI: Basel, Switzerland
Share
Email
Facebook
Twitter
LinkedIn

A Novel Supramolecular Approach for Red-Light-Photosensitized Nitric Oxide Release

Giuseppe Longobardi 2
image
image
image
image
Fabiana Quaglia 2
1. PhotoChemLab, Department of Drug and Health Sciences, University of Catania, Catania 95125, Italy, Italy
2. Drug Delivery Laboratory, Department of Pharmacy, University of Napoli Federico II, Naples 80131, Italy., Italy
3. Institute for Polymers, Composites and Biomaterials-National Research Council (IPCB-CNR), Pozzuoli 80078, Italy, Italy
Abstract

Nitric oxide (NO) is an inorganic free radical that plays a multifaceted role in regulating numerous physiological and pathophysiological processes and is gaining increasing recognition as a powerful unconventional therapeutic agent for the treatment of severe diseases, including cancer. However, its high reactivity and the need for precise control over its site- and time-specific release pose significant challenges for clinical translation. Light-triggered delivery of NO from suitable photoprecursors represents a compelling strategy to address these challenges, especially if its delivery times are compatible with therapeutic windows.

Here, we present a conceptually novel supramolecular approach for the catalytic photoactivation of a blue light-responsive NO photodonor (NOPD) using biocompatible red light, which is made possible by photosensitized energy transfer within nanocarriers. This strategy achieves a remarkable red-shift of approximately 300 nm, enabling activation at longer, clinically relevant wavelengths.

By co-encapsulating red light-absorbing photosensitizers (PSs) and the NOPD into various biocompatible nanocarriers, we establish a new photoreactive environment where the PS triplet state initiates NO release through an oxygen-competitive pathway. This ensures effective release under both aerobic and anaerobic conditions, broadening potential biological applications.

Notably, the process also yields a fluorescent photoproduct, offering a built-in optical reporter for real-time monitoring of NO generation. This integrated activation/reporting mechanism, achieved without chemical modification of the NOPD or the use of complex light sources, introduces a versatile and scalable platform for NO-based phototherapies. This work offers a transformative advance in light-mediated NO delivery by uniting supramolecular photochemistry, nanotechnology, and clinical biocompatibility, opening up new avenues for minimally invasive therapeutic strategies.

Keywords
Nitric Oxide
Photosensitizers
Red light
Fluorescence
Biocompatible Nanocarriers
Poster
IOCN 2025 Parisi Cristina.pdf
Nanoparticles for use in wastewater treatment
Co-encapsulation of phytocompounds in liposomes for enhanced wound healing: development and physicochemical characterization